CRNX R&D Expenses

Crinetics Pharmaceuticals Inc · R&D Expenses

CRNX logo

CRNX R&D Expenses

Latest reported$375.45M
CRNX R&D Expenses ($5.10M → $375.45M)
High-resolution chart · PNG

CRNX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crinetics Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
332,058,000
240,156,000
168,527,000
130,225,000
84,255,000
57,598,000
41,506,000
24,479,000
9,233,000
5,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.